The Health Research Council of New Zealand (HRC) and the Ministry of Health have invested in a rapid research response fund to support a range of research projects that will address New Zealand’s evidence needs in relation to the current coronavirus disease (COVID-19) threat, while also contributing to global COVID-19 efforts.
Two distinct funding opportunities are available:
- 2020 COVID-19 New Zealand Rapid Response Research (Request for Proposals)
- 2020 COVID-19 and Emerging Infectious Diseases Grant (Researcher-initiated proposals)
This page contains information to apply for the 2020 COVID-19 and Emerging Infectious Diseases Grant. To apply for the 2020 COVID-19 New Zealand Rapid Response Research RFP, please see the 2020 COVID-19 New Zealand Rapid Response Research RFP page.
This funding opportunity, funded solely by the HRC, is for research that can provide evidence within a short- to medium-term timeframe, with project durations up to 24 months. It aims to fund research relating to COVID-19 that strengthens New Zealand’s research capacity and response to emerging infections disease threats. Proposals that are also able to generate and release some or all of their findings earlier (e.g. within 6 -12 months of commencement) are welcome, in order to support the all-of-government COVID-19 response.
The scope of research is broad with applications encouraged across all fields of health and social science.
Research proposals should align with the New Zealand Health Research Prioritisation Framework and demonstrate the local relevance of the work, as well as its benefits for advancing the health of Māori and Pacific peoples and reducing health inequities. Proposals should also build on, rather than duplicate, global research efforts and demonstrate a commitment to international solidarity and collaboration.
A funding pool of $2 million (exclusive of GST) is available. Within this funding pool, the HRC expects to fund multiple projects across a range of values. Proposals with a duration of up to 24 months are invited.
If you're the first-named investigator (i.e. lead researcher) on an application, you must be based in New Zealand and employed with a New Zealand host organisation.
Collaborating researchers from outside New Zealand can, at the HRC’s discretion, be included as named investigators on an HRC contract. However, the HRC will not contribute to the overhead of the overseas investigator, and the total proportion of contract budget allocated to overseas investigators must not exceed 20 per cent.
For more information about our contract requirements, please read the HRC Rules document under 'Helpful links'.
We advise applicants to carefully choose the most suitable COVID-19 funding opportunity for their proposed research, with consideration to how and when research findings could be disseminated and applied.
If you’re applying for funding through this researcher-initiated funding opportunity, you’ll need to submit a registration via HRC Gateway. You’ll then need to complete an application using the 2020 COVID-19 and Emerging Infectious Diseases Grant Application Form. You will also need to complete the 2020 COVID-19 Budget. Applications are submitted via HRC Gateway and two hard copies sent to the HRC.
Got a question?
If you’ve read through the documents below and the ‘How to apply for HRC funding’ section under ‘Helpful links’ and still have a question about the 2020 COVID-19 and Emerging Infectious Diseases Grant, please contact:
- Fiona Kenning, Research Investment Manager, Research Partnerships 09 303 5208 or firstname.lastname@example.org
- Scott Aitken, Research Investment Manager, Research Partnerships 09 282 4135 or email@example.com.
2020 COVID-19 and Emerging Infectious Diseases Grant Application Guidelines
2 Mar, 2020 9:23am - 468KB